Paloma Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-9,569	Closed	-$512K	–	1986
2020 Q4	$512K	Buy	+9,569	New	+$475K	0.02%	901
2020 Q3	–	Sell	-252,100	Closed	-$12.2M	–	2015
2020 Q2	$12.2M	Buy	+252,100	New	+$12.1M	0.26%	77
2020 Q1	–	Sell	-10,883	Closed	-$466K	–	1175
2019 Q4	$466K	Buy	+10,883	New	+$473K	0.01%	1445
2019 Q3	–	Sell	-25,673	Closed	-$686K	–	1901
2019 Q2	$686K	Sell	25,673 -16,854	-40%	-$431K	0.02%	870
2019 Q1	$1.14M	Buy	42,527 +14,339	+51%	+$335K	0.04%	664
2018 Q4	$456K	Buy	+28,188	New	+$547K	0.02%	706
2017 Q4	–	Sell	-18,200	Closed	-$686K	–	1835
2017 Q3	$686K	Buy	+18,200	New	+$592K	0.02%	1363
2017 Q2	–	Sell	-21,125	Closed	-$726K	–	2119
2017 Q1	$726K	Buy	+21,125	New	+$746K	0.02%	1430
2016 Q4	–	Sell	-28,636	Closed	-$911K	–	1948
2016 Q3	$911K	Sell	28,636 -110,746	-79%	-$3.75M	0.04%	1091
2016 Q2	$4.52M	Buy	+139,382	New	+$4.66M	0.12%	298
2016 Q1	–	Sell	-6,449	Closed	-$229K	–	1826
2015 Q4	$229K	Buy	+6,449	New	+$227K	0.01%	1482
2015 Q3	–	Sell	-7,400	Closed	-$310K	–	1574
2015 Q2	$310K	Buy	+7,400	New	+$286K	0.01%	1314
2014 Q4	–	Sell	-11,650	Closed	-$288K	–	1131
2014 Q3	$288K	Sell	11,650 -12,679	-52%	-$297K	0.02%	730
2014 Q2	$550K	Buy	+24,329	New	+$508K	0.03%	543